Evaluating Current Laparoscopic Applications In Surgery
-
Upload
george-s-ferzli -
Category
Health & Medicine
-
view
2.539 -
download
2
Transcript of Evaluating Current Laparoscopic Applications In Surgery
Evaluating CurrentLaparoscopic Applications
in Surgery
George S Ferzli, MDGeorge S Ferzli, MD
Armando E Castro, MDArmando E Castro, MD
Evidence-Based Medicine
Formulate answerable questions:Formulate answerable questions: Which is superior, open or laparoscopic Which is superior, open or laparoscopic
approach?approach? Is the laparoscopic approach safe?Is the laparoscopic approach safe? Is the laparoscopic approach feasible?Is the laparoscopic approach feasible? Are the outcomes of the laparoscopic Are the outcomes of the laparoscopic
approach acceptable?approach acceptable?
Evidence-Based Medicine
Utilizing available scientific data to develop Utilizing available scientific data to develop guidelines for medical practiceguidelines for medical practice
Used to evaluate and integrate emerging Used to evaluate and integrate emerging techniques and advances into practicetechniques and advances into practice
Laparoscopy lends itself to evaluation and practice Laparoscopy lends itself to evaluation and practice through evidence-based medicinethrough evidence-based medicine
Evidence-Based Medicine
Evidence-Based Medicine
Evidence-Based Medicine
What does the available and most current What does the available and most current data tell us regarding the practice of data tell us regarding the practice of laparoscopy in general surgery?laparoscopy in general surgery?
Laparoscopic Applications in Surgery
EsophagusEsophagus StomachStomach PancreasPancreas LiverLiver
ColonColon AppendixAppendix AdrenalAdrenal SpleenSpleen Groin herniaGroin hernia
Laparoscopic Applications - Esophagus
What are some of the current uses of What are some of the current uses of laparoscopy in esophageal surgery?laparoscopy in esophageal surgery?
Achalasia – Heller MyotomyAchalasia – Heller Myotomy Hiatal hernia/GERD – FundoplicationHiatal hernia/GERD – Fundoplication Epiphrenic DiverticulumEpiphrenic Diverticulum CancerCancer
Laparoscopic Applications - EsophagusAchalasia Surgical treatment of achalasia: current status and Surgical treatment of achalasia: current status and
controversiescontroversies Literature review of the current management of Literature review of the current management of
achalasiaachalasia Laparoscopic Heller myotomy is generally Laparoscopic Heller myotomy is generally
accepted as the operative procedure of choice accepted as the operative procedure of choice Less invasive, associated with less pain and Less invasive, associated with less pain and
postoperative disability, shorter hospital staypostoperative disability, shorter hospital stay
Abir F et al, Dig Surg 2004;21:165-176
Laparoscopic Applications - EsophagusAchalasia
Abir F et al, Dig Surg 2004;21:165-176
•Studies of laparoscopic Heller myotomy
Laparoscopic Applications - EsophagusAchalasia
NN% symptom % symptom
improvementimprovement% post-op % post-op
GERDGERD
Open trans-Open trans-abdominalabdominal 26802680 8383 12.312.3
Open trans-Open trans-thoracicthoracic 13791379 8686 10.510.5
ThoracoscopicThoracoscopic 204204 7676 3535
LaparoscopicLaparoscopic 499499 9494 1313
Laparoscopic Applications - EsophagusAchalasia The laparoscopic approach has a good to The laparoscopic approach has a good to
excellent response rate compared to other excellent response rate compared to other surgical approaches surgical approaches
Lower incidence of postoperative GERD Lower incidence of postoperative GERD than open or thoracoscopic approachesthan open or thoracoscopic approaches
Based on current evidence, laparoscopic Based on current evidence, laparoscopic Heller myotomy is the operative procedure Heller myotomy is the operative procedure of choice for achalasiaof choice for achalasia
Abir F et al, Dig Surg 2004;21:165-176
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic Laparoscopic
antireflux surgery is a antireflux surgery is a well-established well-established treatment of moderate treatment of moderate to severe GERDto severe GERD
Indicated for Indicated for symptomatic pts who symptomatic pts who have not responded have not responded fully to medical fully to medical therapy therapy
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic antireflux surgery Laparoscopic antireflux surgery
for gastroesophageal reflux for gastroesophageal reflux disease: experience with 688 disease: experience with 688 laparoscopic antireflux laparoscopic antireflux proceduresprocedures Review of author’s Review of author’s
experience with GERDexperience with GERD 24 pH monitoring, 24 pH monitoring,
esophageal manometry, and esophageal manometry, and analysis of failure analysis of failure prospectively reviewedprospectively reviewed
Granderath F et al, Int J Col Dis 2004 Jan;18(1):73-77
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic antireflux surgery Laparoscopic antireflux surgery
for gastroesophageal reflux for gastroesophageal reflux disease: experience with 688 disease: experience with 688 laparoscopic antireflux laparoscopic antireflux proceduresprocedures Overall complication 7.6%Overall complication 7.6% Mean f/u 4.8 years with Mean f/u 4.8 years with
normal 24-h pH and normal 24-h pH and esophageal manometry in esophageal manometry in 93% of pts93% of pts
Granderath F et al, Int J Col Dis 2004 Jan;18(1):73-77
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic antireflux surgery Laparoscopic antireflux surgery
for gastroesophageal reflux for gastroesophageal reflux disease: experience with 688 disease: experience with 688 laparoscopic antireflux laparoscopic antireflux proceduresprocedures Conclusions: Laparoscopic Conclusions: Laparoscopic
antireflux surgery is antireflux surgery is feasible and effective, with feasible and effective, with low morbidity and good to low morbidity and good to excellent functional and excellent functional and symptomatic resultssymptomatic results
Granderath F et al, Int J Col Dis 2004 Jan;18(1):73-77
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic treatment of Laparoscopic treatment of
gastro-oesophageal reflux gastro-oesophageal reflux disease.disease. Reviewed 9 Reviewed 9
randomized trials randomized trials comparing open and comparing open and laparoscopic laparoscopic fundoplicationfundoplication
Combined results of Combined results of these trials confirms these trials confirms advantage of the advantage of the laparoscopic approachlaparoscopic approach
Watson D, Best Pract Res Clin Gastroenterol. 2004 Feb;18(1):19-35
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Laparoscopic treatment of Laparoscopic treatment of
gastro-oesophageal reflux gastro-oesophageal reflux diseasedisease Laparoscopic Laparoscopic
fundoplication is now the fundoplication is now the “gold standard” for the “gold standard” for the management of pts with management of pts with severe GERDsevere GERD
New endoscopic treatments New endoscopic treatments will need to achieve similar will need to achieve similar outcomes before they are outcomes before they are accepted replacements for accepted replacements for laparoscopic approachlaparoscopic approach
Watson D, Best Pract Res Clin Gastroenterol. 2004 Feb;18(1):19-35
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Evidence-based appraisal of antireflux Evidence-based appraisal of antireflux
fundoplicationfundoplication
Catarci M et al, Ann Surg. 2004 Mar;239(3):325-37
Laparoscopic Applications - EsophagusHiatal Hernia/GERD
Catarci M et al, Ann Surg. 2004 Mar;239(3):325-37
Laparoscopic Applications - EsophagusHiatal Hernia/GERD
Catarci M et al, Ann Surg. 2004 Mar;239(3):325-37
Laparoscopic Applications - EsophagusHiatal Hernia/GERD Evidence-based appraisal of antireflux Evidence-based appraisal of antireflux
fundoplicationfundoplication No perioperative deaths were reported in any of the No perioperative deaths were reported in any of the
trialstrials Comparing laparoscopic versus open approach:Comparing laparoscopic versus open approach:
Lower operative morbidity rate, 10.3% vs 26.7%Lower operative morbidity rate, 10.3% vs 26.7% Shorter postoperative stay, 3.1 vs 5.2 daysShorter postoperative stay, 3.1 vs 5.2 days Shorter sick leave, 20.1 vs 35.8 daysShorter sick leave, 20.1 vs 35.8 days
No significant differences in rate of recurrence, No significant differences in rate of recurrence, dysphagia, bloating and reoperation for failuredysphagia, bloating and reoperation for failure
Catarci M et al, Ann Surg. 2004 Mar;239(3):325-37
Laparoscopic Applications - Stomach
Bariatric surgeryBariatric surgery CancerCancer Perforated ulcerPerforated ulcer Gastric outlet Gastric outlet
obstruction/Pyloroplastyobstruction/Pyloroplasty GastrostomyGastrostomy
Roux-en-Y Gastric Bypass
Good long-term results, EWL Good long-term results, EWL 60-75%60-75%
Solid food well toleratedSolid food well tolerated
Complications:Complications: Early: anastomotic leak, Early: anastomotic leak,
acute gastric dilatation, acute gastric dilatation, Roux-en-Y obstruction, Roux-en-Y obstruction, atelectasis, DVT/PEatelectasis, DVT/PE
Late: stomal stricture, staple Late: stomal stricture, staple line failure, pouch dilatation, line failure, pouch dilatation, dumping, anemia, vit Bdumping, anemia, vit B1212 deficiency, Cadeficiency, Ca+2 +2
deficiency/osteoporosisdeficiency/osteoporosis
Vertical Banded Gastroplasty
Edward E. Mason (1982), Edward E. Mason (1982), University of IowaUniversity of Iowa
Restriction with polypropylene Restriction with polypropylene band, Marlex mesh, or silastic band, Marlex mesh, or silastic ring ring
Rules of eatingRules of eating
Soft calorie syndromeSoft calorie syndrome
Complications: Complications: LeakLeak Persistent vomitingPersistent vomiting
Laparoscopic Adjustable Gastric Banding
Kuzmak (1990), Lodz Medical Kuzmak (1990), Lodz Medical Academy,Poland Academy,Poland
Adjustable band connected to port Adjustable band connected to port implanted in subcutaneous tissueimplanted in subcutaneous tissue
Complications:Complications: OOperative: sperative: splenic and plenic and
esophageal esophageal injury, injury, conversion to open procedureconversion to open procedure
Late: bLate: band slippage, reservoir and slippage, reservoir deflation/leak, failure to lose deflation/leak, failure to lose weight, persistent vomiting, weight, persistent vomiting, acid refluxacid reflux
Laparoscopic Applications - StomachGastric bypass The laparoscopic The laparoscopic
gastric bypass is now gastric bypass is now the preferred surgical the preferred surgical treatment for morbid treatment for morbid obesityobesity
Laparoscopic Applications - StomachGastric bypass Laparoscopic versus open Laparoscopic versus open
gastric bypass to treat gastric bypass to treat morbid obesitymorbid obesity Presentation of Presentation of
selected series of Roux selected series of Roux en Y gastric bypassen Y gastric bypass
Brolin R, Ann Surg. 2004 Apr;239(4):438-440
Laparoscopic Applications - StomachGastric bypass
Comprehensive review of Comprehensive review of 18 published cohort studies 18 published cohort studies (10 laparoscopic, 8 open) (10 laparoscopic, 8 open) favored laparoscopyfavored laparoscopy
Shorter LOSShorter LOS Lower incidence of Lower incidence of
abdominal wall herniasabdominal wall hernias Mortality and wound Mortality and wound
infection rate in infection rate in combined cohort combined cohort studies also favors the studies also favors the laparosopic approach laparosopic approach versus openversus open
Brolin R, Ann Surg. 2004 Apr;239(4):438-440
Laparoscopic Applications - StomachGastric bypass
In combined cohort In combined cohort studies the open studies the open approach had a approach had a significantly lower significantly lower incidence of late stomal incidence of late stomal stenosis and bowel stenosis and bowel obstructionobstruction
Brolin R, Ann Surg. 2004 Apr;239(4):438-440
Laparoscopic Applications - StomachGastric bypass Laparoscopic versus open gastric bypass to treat Laparoscopic versus open gastric bypass to treat
morbid obesitymorbid obesity
Brolin R, Ann Surg. 2004 Apr;239(4):438-440
Laparoscopic Applications - StomachCancer Comparison of laparoscopic and open gastrectomy Comparison of laparoscopic and open gastrectomy
for malignant diseasefor malignant disease Retrospective case-matched study comparing Retrospective case-matched study comparing
laparoscopic (n = 12) and open (n = 13) partial laparoscopic (n = 12) and open (n = 13) partial gastrectomies for cancergastrectomies for cancer
Stage, extent of lymphadenectomy, and 18 Stage, extent of lymphadenectomy, and 18 month survival were comparedmonth survival were compared
Weber KJ et al, Surg Endosc. 2003 Jun;17(6):968-71.
Laparoscopic Applications - StomachCancer Comparison of laparoscopic and open gastrectomy Comparison of laparoscopic and open gastrectomy
for malignant diseasefor malignant disease No statistical difference in stages between No statistical difference in stages between
groupsgroups Resection margins in laparoscopic group were Resection margins in laparoscopic group were
all free of tumorall free of tumor No difference in extent of lymphadenectomy No difference in extent of lymphadenectomy
between groupsbetween groups No difference in survival between groups at 18 No difference in survival between groups at 18
month follow-upmonth follow-upWeber KJ et al, Surg Endosc. 2003 Jun;17(6):968-71.
Laparoscopic Applications - StomachCancer Comparison of laparoscopic and open gastrectomy Comparison of laparoscopic and open gastrectomy
for malignant diseasefor malignant disease Conclusions: The laparoscopic approach to Conclusions: The laparoscopic approach to
gastric cancer allows for adequate margins and gastric cancer allows for adequate margins and can follow oncologic principles, and is this an can follow oncologic principles, and is this an viable alternative to open surgeryviable alternative to open surgery
There is no difference in short-term survival There is no difference in short-term survival between the two approachesbetween the two approaches
Weber KJ et al, Surg Endosc. 2003 Jun;17(6):968-71.
Laparoscopic Applications - StomachCancer Application of minimally invasive treatment for Application of minimally invasive treatment for
early gastric cancer.early gastric cancer. To propose indications for the application of To propose indications for the application of
minimally invasive therapy for EGCminimally invasive therapy for EGC Retrospective analysis of 566 pts who had Retrospective analysis of 566 pts who had
undergone gastrectomy with D2 or more undergone gastrectomy with D2 or more extended lymphadenectomyextended lymphadenectomy
Risk factors for lymph node metastasis were Risk factors for lymph node metastasis were identifiedidentified
Hyung WJ et al, J Surg Oncol. 2004 Mar 15;85(4):181-5.
Laparoscopic Applications - StomachCancer Application of minimally invasive treatment for Application of minimally invasive treatment for
early gastric cancer.early gastric cancer. Lymph node metastasis was associated with Lymph node metastasis was associated with
submucosal invasion, larger tumor size, submucosal invasion, larger tumor size, undifferentiated histology and presence of undifferentiated histology and presence of lymphatic or vascular invasion (LBVI)lymphatic or vascular invasion (LBVI)
Minimally invasive treatment can be possibly Minimally invasive treatment can be possibly applied for pts with EGC using these four applied for pts with EGC using these four independent risk factors for lymph node independent risk factors for lymph node metastasismetastasis
Hyung WJ et al, J Surg Oncol. 2004 Mar 15;85(4):181-5.
Laparoscopic Applications - StomachCancer Current status of laparoscopic gastrectomy for Current status of laparoscopic gastrectomy for
cancer in Japan.cancer in Japan. Review of current indications for and outcomes Review of current indications for and outcomes
of laparoscopic procedures for gastric cancerof laparoscopic procedures for gastric cancerLaparoscopic wedge resection (LWR)Laparoscopic wedge resection (LWR)Intragastric mucosal resection (IGMR)Intragastric mucosal resection (IGMR)Laparoscopy-assisted distal gastrectomy Laparoscopy-assisted distal gastrectomy
(LADG)(LADG)
Kitano S et al, Surg Endosc. 2004 Feb;18(2):182-5.
Laparoscopic Applications - StomachCancer Current status of laparoscopic gastrectomy for Current status of laparoscopic gastrectomy for
cancer in Japan.cancer in Japan. Laparoscopic procedures are useful in early gastric Laparoscopic procedures are useful in early gastric
cancer (EGC) because ofcancer (EGC) because of Minimal invasivenessMinimal invasiveness Decreased painDecreased pain Faster recoveryFaster recovery
Improved outcomes with laparoscopic approaches for Improved outcomes with laparoscopic approaches for EGC have led to the application of these approaches to EGC have led to the application of these approaches to more advanced gastric cancermore advanced gastric cancer
Kitano S et al, Surg Endosc. 2004 Feb;18(2):182-5.
Laparoscopic Applications - StomachCancer
Kitano S et al, Surg Endosc. 2004 Feb;18(2):182-5.
LaparoscopicLaparoscopic local resectionlocal resection
IGMRIGMR LWRLWR Lap GastrectomyLap Gastrectomy
Number of casesNumber of cases 260260 14281428 26002600
IndicationIndication Early gastric Early gastric cancer cancer withoutwithout risk risk of LN metsof LN mets
Early gastric Early gastric cancer cancer withwith risk of risk of LN metsLN mets
Complication rateComplication rate
IntraoperativeIntraoperative 4.24.2 2.12.1 1.41.4
PostoperativePostoperative 6.56.5 4.64.6 9.79.7
•Laparoscopic surgery for gastric cancer in Japan
Laparoscopic Applications - StomachCancer Current status of laparoscopic gastrectomy for cancer in Current status of laparoscopic gastrectomy for cancer in
Japan.Japan. Conclusions:Conclusions:
Indication for LWR and IGMR is cancer Indication for LWR and IGMR is cancer without risk of lymph node metastasis, without risk of lymph node metastasis,
Indication for LADG is early gastric cancer Indication for LADG is early gastric cancer with risk of perigastric (n1) lymph node with risk of perigastric (n1) lymph node metastasismetastasis
Multicenter randomized control studies of Multicenter randomized control studies of long-term outcome are necessarylong-term outcome are necessary
Kitano S et al, Surg Endosc. 2004 Feb;18(2):182-5.
Laparoscopic Applications - Pancreas
What are some of the current uses of What are some of the current uses of laparoscopy in pancreatic surgery?laparoscopy in pancreatic surgery?
DiagnosticDiagnostic TherapeuticTherapeutic
Laparoscopic Applications - PancreasDiagnostic Pancreatic surgery in the laparoscopic eraPancreatic surgery in the laparoscopic era
Diagnostic laparoscopy has been used to detect Diagnostic laparoscopy has been used to detect peritoneal metastases and obtain biopsies since peritoneal metastases and obtain biopsies since 1960’s1960’s
Staging laparoscopy avoids unnecessary Staging laparoscopy avoids unnecessary laparotomy in one-fifth of patients with laparotomy in one-fifth of patients with pancreatic cancerpancreatic cancer
The addition of laparoscopic ultrasound may The addition of laparoscopic ultrasound may also be beneficial in detection of intrahepatic also be beneficial in detection of intrahepatic metastases and vascular involvementmetastases and vascular involvement
Ammori B, J Pancreas 2003;4(6):187-192
Laparoscopic Applications - PancreasTherapeutic Pancreatic resectionPancreatic resection
Laparoscopic Applications - PancreasTherapeutic Laparoscopic Laparoscopic
pancreatic surgery. pancreatic surgery. Current indications Current indications and surgical resultsand surgical results Evaluated the Evaluated the
outcomes and outcomes and feasibility of feasibility of laparoscopic laparoscopic pancreatic surgerypancreatic surgery
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic
Fifteen patients (8M, Fifteen patients (8M, 7F)7F)
Distal pancreatectomy Distal pancreatectomy (DP) for solid tumor (DP) for solid tumor (n=4)(n=4)
DP for cystic lesion DP for cystic lesion (n=3)(n=3)
DP for chronic DP for chronic pancreatitis (n=2)pancreatitis (n=2)
Cystgastrostomy (CG) Cystgastrostomy (CG) for pseudocyst (n=4)for pseudocyst (n=4)
Enucleation of Enucleation of insulinoma (n=2)insulinoma (n=2)
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic Laparoscopic Laparoscopic
pancreatic surgery. pancreatic surgery. Current indications Current indications and surgical resultsand surgical results Mean OR time was Mean OR time was
249+/-70 min249+/-70 min DP DP ~5 hrs, CG and ~5 hrs, CG and
enucleation ~3hrsenucleation ~3hrs Mean blood loss Mean blood loss
was 138+/-184gwas 138+/-184g
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic
2 DP were 2 DP were converted to open converted to open
No related mortalityNo related mortality 2 pancreatic fistula 2 pancreatic fistula
(1 DP, 1 (1 DP, 1 enucleation) both enucleation) both treated non-treated non-operativelyoperatively
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic Laparoscopic pancreatic Laparoscopic pancreatic
surgery. Current surgery. Current indications and surgical indications and surgical resultsresults
ConclusionsConclusions Laparoscopic pancreatic Laparoscopic pancreatic
surgery (LPS) is safe and surgery (LPS) is safe and feasible for patients with feasible for patients with benign tumors and cystic benign tumors and cystic lesionslesions
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic
Although some Although some retrospective studies retrospective studies have shown that LPS have shown that LPS results in faster post-op results in faster post-op recovery and morbidity recovery and morbidity rates comparable to rates comparable to open surgery, no open surgery, no randomized controlled randomized controlled study confirming study confirming reduced invasiveness reduced invasiveness or superiority has been or superiority has been presentedpresented
Shimizu S et al, Surg Endosc 2004 Mar; 18(3):402-6
Laparoscopic Applications - PancreasTherapeutic Laparoscopic resection of Laparoscopic resection of
the pancreas. A feasibility the pancreas. A feasibility study of the short-term study of the short-term outcomeoutcome 32 patients with pancreatic 32 patients with pancreatic
disease were evaluateddisease were evaluated Neuroendocrine tumors Neuroendocrine tumors
(n=13)(n=13) Unspecified tumors Unspecified tumors
(n=11)(n=11)
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic
Cysts (n=2)Cysts (n=2) ITP with ectopic ITP with ectopic
spleen (n=2)spleen (n=2) Annular pancreas Annular pancreas
(n=1)(n=1) Trauma (n=1)Trauma (n=1) Splenic artery Splenic artery
aneurysm (n=)aneurysm (n=) Adenocarcinoma Adenocarcinoma
(n=1)(n=1)
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic Laparoscopic resection Laparoscopic resection
of the pancreas. A of the pancreas. A feasibility study of the feasibility study of the short-term outcomeshort-term outcome Enucleations (n=6)Enucleations (n=6) Distal Distal
pancreatectomy pancreatectomy (DP) with (DP) with splenectomy (n=12)splenectomy (n=12)
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic
DP without DP without splenectomy (n=5)splenectomy (n=5)
Laparoscopic Laparoscopic exploration only (n=3)exploration only (n=3)
Five procedures (13%) Five procedures (13%) converted to openconverted to open
One resection One resection converted to hand-converted to hand-assisted assisted
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic Laparoscopic resection of the Laparoscopic resection of the
pancreas. A feasibility study of pancreas. A feasibility study of the short-term outcomethe short-term outcome Mortality rate for Mortality rate for
laparoscopic resection 8.2% laparoscopic resection 8.2% (2/24)(2/24)
Complications occurred Complications occurred after resection in 38% after resection in 38% (9/24)(9/24)
Median hospital stay 5.5 Median hospital stay 5.5 daysdays
Post-op opioids for median Post-op opioids for median of 2 daysof 2 days
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic Laparoscopic resection of Laparoscopic resection of
the pancreas. A feasibility the pancreas. A feasibility study of the short-term study of the short-term outcomeoutcome
ConclusionConclusion Laparoscopic approach Laparoscopic approach
to pancreatic resections to pancreatic resections is feasible in selected is feasible in selected patientspatients
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic
Offers benefits to Offers benefits to patients similar to patients similar to those provided by those provided by minimally invasive minimally invasive procedures for other procedures for other diseasesdiseases
Prospective Prospective randomized trials randomized trials needed to confirm needed to confirm potential benefitspotential benefits
Edwin B et al, Surg Endosc 2004 Mar; 18(3):407-411
Laparoscopic Applications - PancreasTherapeutic Pancreatic pseudocystPancreatic pseudocyst
Laparoscopic Applications - PancreasPseudocyst Minimally invasive Minimally invasive
approaches to the approaches to the management of management of pancreatic pseudocystspancreatic pseudocysts Endogastric, Endogastric,
transgastric and transgastric and extragastric extragastric techniques techniques describeddescribed
Bhattacharya D et al, Surg Laparosc Endosc Percutan Tech 2003 Jun;13(3):141-148
Laparoscopic Applications - PancreasPseudocyst
Approximately 40 Approximately 40 cases described cases described
Median post-op stay 4 Median post-op stay 4 daysdays
89% success rate89% success rate No recurrences at No recurrences at
median f/u 6-32 median f/u 6-32 monthsmonths
Complications in 2 Complications in 2 patients (7%)patients (7%)
Bhattacharya D et al, Surg Laparosc Endosc Percutan Tech 2003 Jun;13(3):141-148
Laparoscopic Applications - PancreasPseudocyst Minimally invasive approaches to the Minimally invasive approaches to the
management of pancreatic pseudocystsmanagement of pancreatic pseudocysts
Bhattacharya D et al, Surg Laparosc Endosc Percutan Tech 2003 Jun;13(3):141-148
Laparoscopic Applications - Liver
What are some of the What are some of the uses of laparoscopy in uses of laparoscopy in liver surgery?liver surgery? Liver resectionLiver resection
Laparoscopic Applications - Liver
Laparoscopic liver Laparoscopic liver surgery: analyze the surgery: analyze the experience on 36 casesexperience on 36 cases Laparoscopic Laparoscopic
fenestration and fenestration and drainage were used in drainage were used in 7 patients with 7 patients with nonparasitic liver cystsnonparasitic liver cysts
Popescu I et al, Chirurgia. 2003 Jul-Aug;98(4):307-17
Laparoscopic Applications - Liver
Nine patients had hydatid Nine patients had hydatid cystscysts
7/9 partial 7/9 partial pericystectomy after pericystectomy after inactivation and inactivation and evacuationevacuation
2/9 ideal 2/9 ideal pericystectomy in pericystectomy in segments II and IIIsegments II and III
Only in the case of Only in the case of metastasis was a left lateral metastasis was a left lateral sectorectomy performed sectorectomy performed (all other resections were (all other resections were non-anatomical)non-anatomical)
Popescu I et al, Chirurgia. 2003 Jul-Aug;98(4):307-17
Laparoscopic Applications - Liver
Laparoscopic liver Laparoscopic liver surgery: analyze the surgery: analyze the experience on 36 casesexperience on 36 cases No mortalityNo mortality 11.11% morbidity11.11% morbidity Mean f/u 18 monthsMean f/u 18 months
All patients All patients asymptomaticasymptomatic
Popescu I et al, Chirurgia. 2003 Jul-Aug;98(4):307-17
Laparoscopic Applications - Liver
Benefits are those Benefits are those of minimally-of minimally-invasive surgeryinvasive surgery
LessLess abdominal abdominal wall trauma, early wall trauma, early mobilization, mobilization, shorter LOS, shorter LOS, aestheticsaesthetics
Popescu I et al, Chirurgia. 2003 Jul-Aug;98(4):307-17
Laparoscopic Applications - Liver
Laparoscopic liver Laparoscopic liver resection: benefits and resection: benefits and controversiescontroversies Comparative studies often Comparative studies often
favor laparoscopic over favor laparoscopic over open approachopen approach
Decreased analgesic Decreased analgesic requirementrequirement
Shorter delay to oral Shorter delay to oral intakeintake
Decreased hospital stayDecreased hospital stay Quicker improvement Quicker improvement
in transaminase levelsin transaminase levels
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
These advantages are These advantages are most commonly seen most commonly seen in patients undergoing in patients undergoing cyst or benign tumor cyst or benign tumor resectionsresections
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
Laparoscopic liver Laparoscopic liver resection: benefits and resection: benefits and controversiescontroversies Comparison of Comparison of
survival of patients survival of patients after laparoscopic after laparoscopic malignant tumor malignant tumor resection to open resection to open approach is not approach is not establishedestablished
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
Bleeding and bile Bleeding and bile leakage are the most leakage are the most common perioperative common perioperative complicationscomplications
Difficult to control Difficult to control laparoscopicallylaparoscopically
Often lead to Often lead to conversion to open conversion to open approachapproach
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
Laparoscopic liver Laparoscopic liver resection: benefits and resection: benefits and controversiescontroversies
Literature review Literature review revealed the revealed the following:following: 709 patients have 709 patients have
undergone undergone laparoscopic liver laparoscopic liver surgerysurgery
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
Benign lesions 490 Benign lesions 490 (69%)(69%)
Malignant lesions Malignant lesions 195 (27.5%)195 (27.5%)
Complications 99 Complications 99 (14%)(14%)
Conversion to open Conversion to open surgery 36 (5%)surgery 36 (5%)
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
ProcedureProcedure NN %%
Cyst fenestration/unroofingCyst fenestration/unroofing 245245 3333
Non-anatomical resectionsNon-anatomical resections 225225 30.530.5
Anatomical resectionsAnatomical resections 152152 2020
Laparoscopic cryoablationLaparoscopic cryoablation 3838 5.55.5
Laparoscopic RFALaparoscopic RFA 3434 4.54.5
Gasless laparoscopyGasless laparoscopy 2525 3.33.3
PericystectomyPericystectomy 1010 1.51.5
Hand-assisted laparoscopic hepatectomyHand-assisted laparoscopic hepatectomy 1010 1.51.5
Laparoscopic donor hepatectomyLaparoscopic donor hepatectomy 22 0.20.2
TotalTotal 741741 100100
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
•Laparoscopic procedures for liver lesions
Laparoscopic Applications - Liver
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
•Perioperative and postoperative complications
ComplicationComplication NN %%
AscitesAscites 1212 1.71.7
Pleural effusionPleural effusion 99 1.21.2
HemorrhageHemorrhage 88 1.11.1
Bile LeakBile Leak 55 0.70.7
Hepatic failureHepatic failure 55 0.70.7
InfectionsInfections 55 0.70.7
Incisional herniaIncisional hernia 44 0.60.6
Bowel obstructionBowel obstruction 33 0.40.4
Bowel injury not requiring conversionBowel injury not requiring conversion 33 0.30.3
ColitisColitis 11 0.10.1
PhlebitisPhlebitis 11 0.10.1
Pyoderma gangrenosumPyoderma gangrenosum 11 0.10.1
TotalTotal 5656 100100
Laparoscopic Applications - Liver
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
•Conversions to open hepatectomy
ConversionConversion NN %%
HemorrhageHemorrhage 1919 2.72.7
Insufficient tumor excisionInsufficient tumor excision 99 1.31.3
AdhesionsAdhesions 44 0.50.5
Insufficient resection (positive margins)Insufficient resection (positive margins) 22 0.30.3
Gas embolusGas embolus 22 0.30.3
Severe cirrhosisSevere cirrhosis 11 0.10.1
Instrument malfunctionInstrument malfunction 11 0.10.1
TotalTotal 3636 5.35.3
Laparoscopic Applications - Liver
Laparoscopic liver resection: benefits and Laparoscopic liver resection: benefits and controversiescontroversies
SummarySummary Laparoscopic liver resection is safe and feasibleLaparoscopic liver resection is safe and feasible Small tumors in left lateral segment are the Small tumors in left lateral segment are the
most amenable to laparoscopic approachmost amenable to laparoscopic approach Complication and conversion rates are Complication and conversion rates are
acceptableacceptable
Gagner M et al, Surg Clin North Am. 2004 Apr;84(2):451-62
Laparoscopic Applications - Liver
Current status of the laparoscopic approach to Current status of the laparoscopic approach to liver resectionliver resection Over 700 reported laparoscopic liver Over 700 reported laparoscopic liver
procedures performed since 1991procedures performed since 1991 70% for benign lesions, 30% malignant tumors70% for benign lesions, 30% malignant tumors Cyst fenestration and unroofing most frequently Cyst fenestration and unroofing most frequently
performed procedure (245 patients)performed procedure (245 patients) Overall morbidity 12% (56 patients)Overall morbidity 12% (56 patients) Overall conversion rate 11% (36 patients)Overall conversion rate 11% (36 patients)
Rogula T et al, J Long Term Eff Med Implants. 2004;14(1):23-31
Laparoscopic Applications - Liver
Current status of the laparoscopic approach to Current status of the laparoscopic approach to liver resectionliver resection
ConclusionConclusion Laparoscopic liver resection is safe and Laparoscopic liver resection is safe and
feasiblefeasible Acceptable morbidity and mortalityAcceptable morbidity and mortality Results should be confirmed with Results should be confirmed with
prospective studiesprospective studies
Rogula T et al, J Long Term Eff Med Implants. 2004;14(1):23-31
Laparoscopic Applications - Colon
Diverticular diseaseDiverticular disease Resection for malignancyResection for malignancy
Laparoscopic Applications - Colon
Resection for Resection for diverticular diseasediverticular disease
Laparoscopic Applications - ColonDiverticular Disease Laparoscopic Laparoscopic
treatment of sigmoid treatment of sigmoid diverticulitisdiverticulitis Retrospective review Retrospective review
of 103 patients treated of 103 patients treated for Hinchey I-III for Hinchey I-III diverticulitisdiverticulitis
One-stage laparoscopic One-stage laparoscopic resection with primary resection with primary anastamosis planned anastamosis planned procedureprocedure
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease
Hinchey IIa patients Hinchey IIa patients with abscesses were with abscesses were drained drained percutaneously pre-percutaneously pre-operativelyoperatively
Hinchey III patients Hinchey III patients underwent underwent emergency surgeryemergency surgery
Four-trocar approach Four-trocar approach with left iliac fossa with left iliac fossa minilaparotomy usedminilaparotomy used
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease Laparoscopic treatment of Laparoscopic treatment of
sigmoid diverticulitissigmoid diverticulitis Laparoscopic treatment Laparoscopic treatment
successfully completed in successfully completed in 100 patients100 patients
2.9% intra-operative 2.9% intra-operative complicationscomplications
1 uretheric injury in H31 uretheric injury in H3 2 anastamotic failure in 2 anastamotic failure in
H1 and H2aH1 and H2a 2 conversions due to 2 conversions due to
anatomic difficultiesanatomic difficulties
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease Laparoscopic treatment of Laparoscopic treatment of
sigmoid diverticulitissigmoid diverticulitis 8% post-operative 8% post-operative
procedure related morbidityprocedure related morbidity 3 wound infection (2 in 3 wound infection (2 in
HI, 1 in H3)HI, 1 in H3) 2 anastamotic leak (1 in 2 anastamotic leak (1 in
HI, 1 in H2a)HI, 1 in H2a) 1 intestinal obstruction 1 intestinal obstruction
(HI)(HI)
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease
1 anastamotic bleed 1 anastamotic bleed (HI)(HI)
1 intraperitoneal 1 intraperitoneal bleed (HI)bleed (HI)
2 pneumonia (H3)2 pneumonia (H3) No mortalityNo mortality Longer LOS for H2b Longer LOS for H2b
patients treated for patients treated for colovesical fistulacolovesical fistula
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease Laparoscopic treatment of Laparoscopic treatment of
sigmoid diverticulitissigmoid diverticulitis There were no There were no
significant differences significant differences between classes of between classes of patients (HI-III) with patients (HI-III) with regard toregard to
Operating timeOperating time Nasogastgric tube Nasogastgric tube
daysdays
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease
There were no There were no significant differences significant differences between classes of between classes of patients (HI-III) with patients (HI-III) with regard toregard to
Post-operative ileus Post-operative ileus daysdays
Days to oral intakeDays to oral intake LOSLOS
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease Laparoscopic Laparoscopic
treatment of sigmoid treatment of sigmoid diverticulitisdiverticulitis
ConclusionConclusion Laparoscopic resection Laparoscopic resection
for diverticulitis can be for diverticulitis can be performed without performed without additional morbidity in additional morbidity in
HIHI
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - ColonDiverticular Disease
Laparoscopic treatment Laparoscopic treatment of sigmoid of sigmoid diverticulitis can be a diverticulitis can be a safe and effective gold safe and effective gold standard procedure for standard procedure for HI-III patients in HI-III patients in experienced handsexperienced hands
Pugliese R et al, Surg Endosc. 2004 Jun;18:1334-1348
Laparoscopic Applications - Colon
Colectomy for colon Colectomy for colon cancercancer
Laparoscopic Applications - ColonResection for malignancy Laparoscopy-assisted Laparoscopy-assisted
colectomy versus open colectomy versus open colectomy for treatment of colectomy for treatment of non-metastatic colon non-metastatic colon cancer: a randomised trialcancer: a randomised trial Comparing the efficacy Comparing the efficacy
of laparoscopy-assisted of laparoscopy-assisted colectomy (LAC) and colectomy (LAC) and open colectomy (OC) open colectomy (OC) in terms of tumor in terms of tumor recurrence and survivalrecurrence and survival
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy
219 patients 219 patients randomised to LAC or randomised to LAC or open colectomyopen colectomy
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy Patients in the LAC group Patients in the LAC group
had decreased time to had decreased time to peristalsis and oral intake peristalsis and oral intake than OCthan OC
Patients with LAC had Patients with LAC had shorter LOS than open shorter LOS than open groupgroup
Morbidity was lower in Morbidity was lower in LAC than OCLAC than OC
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy Probability of cancer-Probability of cancer-
related survival was related survival was higher in the LAC group higher in the LAC group than OCthan OC
In patients with stage III In patients with stage III tumors, LAC was tumors, LAC was independently associated independently associated with reduced risk of tumor with reduced risk of tumor relapse and death from relapse and death from cancer-related cause cancer-related cause compared to OCcompared to OC
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy Conclusion:Conclusion:
LAC is more LAC is more effective then OC in the effective then OC in the treatment of colon cancer treatment of colon cancer in terms of morbidity, in terms of morbidity, LOS, tumor recurrence LOS, tumor recurrence and cancer-related and cancer-related survivalsurvival
Lacy AM et al, Lancet. 2003 Jun 29;359(9325):2224-9
Laparoscopic Applications - ColonResection for malignancy A comparison of A comparison of
laparoscopically assisted and laparoscopically assisted and open colectomy for colon open colectomy for colon cancercancer Prospective, randomized Prospective, randomized
trial 428 patients underwent trial 428 patients underwent open colectomy (OC), 435 open colectomy (OC), 435 patients underwent patients underwent laparoscopically assisted laparoscopically assisted colectomy (LAC)colectomy (LAC)
Primary endpoint was time Primary endpoint was time to tumor recurrenceto tumor recurrence
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy Surgery:Surgery:
Operating times longer for Operating times longer for LAC LAC
Extent of resection similar Extent of resection similar in both groupsin both groups
Margins <5cm in Margins <5cm in 6% OC vs 5% in 6% OC vs 5% in LACLAC
Median number of 12 Median number of 12 lymph nodes examined in lymph nodes examined in eacheach
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy Recovery/Complications - No Recovery/Complications - No
significant difference in:significant difference in: Rate of intraoperative Rate of intraoperative
complicationscomplications 30-day postoperative 30-day postoperative
mortalitymortality Rate/severity of Rate/severity of
postoperative complications postoperative complications at dischargeat discharge
Rates of readmissionRates of readmission
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy Survival and Recurrence Survival and Recurrence
at 4.4 years - No at 4.4 years - No significant difference in:significant difference in: Number of patients Number of patients
with recurrence in each with recurrence in each groupgroup
Cumulative incidence Cumulative incidence of recurrence between of recurrence between LAC and OC patientsLAC and OC patients
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy
Overall survival rateOverall survival rate Disease-free survival Disease-free survival
raterate These were true for These were true for
any stageany stage
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy ConclusionConclusion
This data suggests that This data suggests that LAC does not confer LAC does not confer additional risk for additional risk for cancer recurrencecancer recurrence
LAC is an acceptable LAC is an acceptable alternative to OC and alternative to OC and therefore it is safe to therefore it is safe to proceed with LAC in proceed with LAC in patients with colon patients with colon cancercancer
COST Study Group, NEJM. 2004 May;350:2050-9
Laparoscopic Applications - ColonResection for malignancy Laparoscopic resection of Laparoscopic resection of
colon cancer Consensus colon cancer Consensus of the European of the European Association of Endoscopic Association of Endoscopic Surgery (E.A.E.S.)Surgery (E.A.E.S.) Review of the current Review of the current
literature to formulate literature to formulate evidence-based evidence-based recommendations on recommendations on the role of laparoscopy the role of laparoscopy in resection of colon in resection of colon cancercancer
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy Laparoscopic resection of Laparoscopic resection of
colon cancercolon cancer Advanced age, obesity and Advanced age, obesity and
prior abdominal surgery are prior abdominal surgery are not absolute not absolute contraindications to contraindications to laparoscopic resection of laparoscopic resection of colon canercolon caner
Conversion is highest in Conversion is highest in presence of bulky or presence of bulky or invasive tumorsinvasive tumors
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy
Operative time is longer for Operative time is longer for laparoscopic resection laparoscopic resection
Specimen size, extent of Specimen size, extent of resection and pathological resection and pathological examination is similar to examination is similar to open resectionopen resection
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy Laparoscopic resection Laparoscopic resection
of colon cancerof colon cancer Immediate Immediate
postoperative postoperative morbidity and morbidity and mortality are mortality are comparable for open comparable for open and laparoscopic and laparoscopic resectionresection
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy
Laparoscopic resection Laparoscopic resection results in results in
decreased paindecreased pain better-preserved better-preserved
pulmonary functionpulmonary function Earlier return of GI Earlier return of GI
functionfunction Decreased LOSDecreased LOS
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy Laparoscopic resection Laparoscopic resection
of colon cancerof colon cancer The postoperative The postoperative
stress response is lower stress response is lower after laparoscopic after laparoscopic resectionresection
The incidence of port The incidence of port site metastasis is <1%site metastasis is <1%
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy
Survival after Survival after laparoscopic resection laparoscopic resection appears to be equal to appears to be equal to that after open that after open resectionresection
The costs for The costs for laparoscopic resection laparoscopic resection is higher than for open is higher than for open resectionresection
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Laparoscopic Applications - ColonResection for malignancy Laparoscopic resection of Laparoscopic resection of
colon cancercolon cancer Laparoscopic resection Laparoscopic resection
for colon cancer is safe for colon cancer is safe and feasible, with and feasible, with improved short-term improved short-term outcomesoutcomes
Results of studies of Results of studies of long-term survival will long-term survival will determine more determine more precisely its roleprecisely its role
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Number of lymph nodes and extent of resection
Study No. of lymph nodes Resection margins (cm)
Laparoscopic Open P value Laparoscopic Openp value
Milsom 19a 25* — Clear in all Clear in all Delgaddo <70 yr 9.6 10.5 NS >70 yr 12.2 10.5 NS Cure 11 10 NS Length 26 25 —Stage 7 8 — Margins 4 4 Lacy 13 12.5 NS Lezoche RHC 14.2 13.8 NS Length 28.3 29.1 NS
LHC 9.1 8.6 NS Length 22.9 24.1 NS
LHC TFM 5.2 5.3 NS
Bouvet 8 10 NS Prox 10 10 NS
Dist 6 9 0.03
Hong 7 7 NS Dist 7.9 7.2 NS
Koehler 14 11 — Length 24.1 22.6 — Prox 13.2 10.1 — Dist 7.9 8.6 —Psaila 7.0 7.7 NS Khalili 12 16 — Lezoche 10.7 11 NS Length 26.8 29.4 NS
LHC TFM 5.2 5.3 NS
Marubashi LoD 1.7 2.25<0.01
Bokey 17 16 NS Prox 10.1 11.0 NS
Dist 10.0 13.4 0.03
Franklin NA NA NS NA NA NSSantoro Leung 9a 8a Dist 3a 3.5a
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Morbidity
Study Laparoscopic (%) Open (%) p value
Lacy 11 29 0.001
Milsom 15 15 NSDelgado 10.9 25.6 0.001
<70 yr 11.4 20.3 NS
>70 yr 10.2 31.3 0.0038
Cure 1.5 5.28 NS
Stage 11 0 —
Lacy 8 30.8 0.04
Schwenk 7 27 0.08
Lezoche RHC 1.9 2.3 NS LHC 7.5 6.3 NS
Bouvet 24 25 NS
Hong Major 15.3 14.6 NS
Minor 11.2 21.5 0.029
Khalili 19 22 NS
Lezoche 13 14.3 NS
Minor 3.6 7.5 NS
Major 9.4 6.8 NS
Marubashi 27.5 25 —Bokey NA NA NS
Franklin Early 17 23.8 NA
Late 5.2 8.9
Santoro Early 28 28 —
Late 12 0
Leung 26 30 NS
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Length of hospital stay
Study Laparoscopic Open p value
Week 5.6 ± 0.26 6.4 ± 0.23 <0.001
Hewitt 6 (57) 7 (4–9) —
Milsom 6.0 (3–37) 7.0 (524) NS
Delgado <70 yr 5 7 0.0001
>70 yr 6 7 0.0009
Curet 5.2 7.3 <0.05
Stage 5 (3–12) 8 (5–30) 0.01
Lacy 5.2 ± 1.2 8.1 ± 3.8 0.0012
Lezoche RHC 9.2 13.2 0.001
LHC 10.0 13.2 0.001
Bouvet 6 (2–35) 7 (4–52) <0.01
Hong 6.9 ± 5.4 10.9 ± 9.3 0.003
Koehler 8.1 (6–14) 15.3 (9–23) —
Psaila 10.7 ± 4.7 17.8 ± 9.5 0.001
Khalili 7.7 ± 0.5 8.2 ± 0.2 NS
Lezoche 10.5 13.3 0.027
Marubashi] 18.7 35.8 <0.0001
Franklin <50 yr 5.2 (2.0–9.2) 9.35 (517) —
>50 yr 7.84 (448) 12.85 (941)
Leung 6 (3–22) 8 (3–28) <0.001
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Overall survival rates
Study Follow-up Laparoscopic (%) Open (%) p value
Lacy 43 mo 82 74 NS
Leung 21.4 mo (median) 90.9 (n = 28) 55.6 (n = 56) NS
Leung 32.8 mo (median) 67.2 (n = 50) 64.1 (n = 50) NS
Khalili 19.6 mo 87.5 (n = 80) 85 (n = 90) NS
Santoro 5 yr 72.3 (n = 50) 68.8 (n = 50) NS
Hong Lap 30.6 mo NA (n = 98) NA (n = 219) NS
Open 21.6 mo
Delgado 42 mo AR 83, SR 87 (n = 31)
Cook Until patient
20 (n = 5)
Hoffman 2 yr Node–: 92 (n = 89)
Node +: 80%
Molenaar 3 yrAll: 59, by Dukes
Quattlebaum 8 mo 90 (n = 10)
Poulin Stage I–III: 24 mo 81
Stage IV: 9 mo
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Disease-free survival rates
Study Follow-up Laparoscopic (%) Open (%) p value
Lacy 43 mo 91 79 0.03
Leung 5 yr 95.2 74.7 NS
Leung 4 yr 80.5 72.9 NS
Feliciotti 48.9 mo 86.5 86.7 NS
Lezoche 42.2 mo RHC 78.3 75.8 NS
42.3 mo LHC 94.1 86.8
Bouvet 26 mo 93 88 NS
Santoro NA 73.2 70.1 NS
Hong Lap 30.6 mo NA NA NS
Open 21.6 mo
Franklin 5 yr 87 80.9 NS
Delgado 42 mo AR: 78
SR: 70
Hoffmant 2 yr Node–: 96
Node +: 79
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Port site metastasis
Study Design n Follow-up PSMLacy RCT 111 Median 43 1Milsom RCT 42 Median 18 0Lacy RCT 31 21.4 0Ballantyne Registry 498 NA 3Fleshman Registry 372 NA 4 (1.3%)Rosato Registry 1071 NA 10 (0.93%)Vukasin Registry 480 >12 5 (1.1%)Schledeck Registry 399 Mean 30 1 (0.25%)
Leung Prospective 217 Mean 19.8 1 (0.65%)Poulin Prospective 172 Mean 24 0Franklin Prospective 191 >30 0Bouvet Prospective 91 26 0Feliciottl Prospective 158 Mean 48.9 2Bokey Retrospective 66 Median 26 1 (0.6%)Fielding Retrospective 149 NA 2 (1.5%)Gellman Retrospective 58 NA 1 (1.7%)Hoffman Retrospective 39 24 0Huscher Retrospective 146 Mean 15 0Leung Retrospective 50 >32 1Khalili Retrospective 80 Mean 21 0Kwo Retrospective 83 NA 2 (2.5%)Leung Retrospective 179 Mean 19.8 1 (0.65%)Lord Retrospective 71 Mean 16.7 0Lumley Retrospective 103 NA 1 (1.0%)Khalili Retrospective 80 Mean 19.6 0Guillou Retrospective 59 NA 1 (1.7%)Larach Retrospective 108 Mean 12.6 0Croce Retrospective 134 NA 1 (0.9%)Kawamura Retrospective 67 (gasless) NA 0 5305
38 (0.72%)
Veldkamp R et al, Surg Endosc. 2004 Jun;18:1163-1185
Approved statement by American Society of Colon and Rectal Surgeons:
Laparoscopic Colectomy for Curable CanerLaparoscopic Colectomy for Curable Caner““Laparoscopic colectomy for curable cancer results in Laparoscopic colectomy for curable cancer results in
equivalent cancer related survival to open colectomy when equivalent cancer related survival to open colectomy when performed by experienced surgeons. Adherence to performed by experienced surgeons. Adherence to
standard cancer resection techniques including but not standard cancer resection techniques including but not limited to complete exploration of the abdomen, adequate limited to complete exploration of the abdomen, adequate proximal and disstal margins, ligation of the major vessels proximal and disstal margins, ligation of the major vessels at their respective origins, containment and careful tissue at their respective origins, containment and careful tissue
handling, and en bloc resection with negative tumor handling, and en bloc resection with negative tumor margins using the laparoscopic approach will result in margins using the laparoscopic approach will result in
acceptable outcomes.”acceptable outcomes.”
Laparoscopic Applications - Appendix
Laparoscopic vs open appendectomy. What is the Laparoscopic vs open appendectomy. What is the real difference? Results of a prospective real difference? Results of a prospective randomized double-blind trialrandomized double-blind trial 52 men randomized to open or laparoscopic 52 men randomized to open or laparoscopic
appendectomy (OA, LA)appendectomy (OA, LA) Operative time, LOS, lost work days, pain Operative time, LOS, lost work days, pain
scores and operative times were comparedscores and operative times were compared
Ignacio RC et al, Surg Endosc. 2004 Mar;18:334-337
Laparoscopic Applications - Appendix
Laparoscopic vs open appendectomy. What is the Laparoscopic vs open appendectomy. What is the real difference?real difference?
No statistically-different difference in:No statistically-different difference in: LOSLOS Post-operative pain days 1 and 7Post-operative pain days 1 and 7 Mean time to return to workMean time to return to work
Operative costs $600 higher for laparoscopic Operative costs $600 higher for laparoscopic groupgroup
Ignacio RC et al, Surg Endosc. 2004 Mar;18:334-337
Laparoscopic Applications - Appendix
Laparoscopic vs open appendectomy. What is the Laparoscopic vs open appendectomy. What is the real difference?real difference?
Conclusions:Conclusions: LA appears to confer no advantage over OA forLA appears to confer no advantage over OA for
LOSLOS Post-operative painPost-operative pain Lost work daysLost work days
Further studies may address possible advantages for Further studies may address possible advantages for specific patient populations (e.g. obese, women)specific patient populations (e.g. obese, women)
Ignacio RC et al, Surg Endosc. 2004 Mar;18:334-337
Laparoscopic Applications - Adrenal
Rationale for Rationale for Laparoscopic Laparoscopic AdrenalectomyAdrenalectomy Small size of most Small size of most
adrenal tumorsadrenal tumors Most adrenal tumors Most adrenal tumors
are benignare benign
Laparoscopic Applications - Adrenal
Open adrenalectomy Open adrenalectomy requires a large requires a large incision for removal of incision for removal of a small tumora small tumor
Lap adrenalectomy Lap adrenalectomy associated with associated with reduced pain, a faster reduced pain, a faster recovery, and fewer recovery, and fewer complicationscomplications
Laparoscopic Applications - Adrenal
Indications for Indications for Laparoscopic Laparoscopic AdrenalectomyAdrenalectomy AldosteronomaAldosteronoma Cushing’s syndromeCushing’s syndrome
Cortisol-producing Cortisol-producing adrenal adenomaadrenal adenoma
Primary adrenal Primary adrenal hyperplasiahyperplasia
Failed treatment of Failed treatment of ACTH-dependent ACTH-dependent Cushing’sCushing’s
Laparoscopic Applications - Adrenal
Pheochromocytoma Pheochromocytoma (sporadic or familial)(sporadic or familial)
Nonfunctioning Nonfunctioning cortical adenoma cortical adenoma (selected cases)(selected cases)
Adrenal metastasesAdrenal metastases
Laparoscopic Applications - Adrenal
Contraindications to Contraindications to Laparoscopic AdrenalectomyLaparoscopic Adrenalectomy Adrenocortical carcinoma Adrenocortical carcinoma Malignant Malignant
pheochromocytomapheochromocytoma Any tumor that appears Any tumor that appears
locally invasivelocally invasive Large adrenal masses (>8-Large adrenal masses (>8-
12cm)12cm) Contraindication to Contraindication to
laparoscopic surgerylaparoscopic surgery
Laparoscopic Applications - Adrenal
Laparoscopic Laparoscopic Adrenalectomy: Difficult Adrenalectomy: Difficult CasesCases Large tumor sizeLarge tumor size Malignant or Malignant or
potentially malignant potentially malignant tumorstumors
Pheochromocytomas –Pheochromocytomas –especially large pheosespecially large pheos
Laparoscopic Applications - Adrenal
Obese patients with Obese patients with Cushing’s syndromeCushing’s syndrome
Obese patientsObese patients Patients with extensive Patients with extensive
previous upper previous upper abdominal surgery abdominal surgery (consider RP approach)(consider RP approach)
Laparoscopic vs. Open Adrenalectomy
Over 12 retrospective Over 12 retrospective studies, no prospective studies, no prospective trialstrials
Operating times are longer Operating times are longer with laparoscopic with laparoscopic adrenalectomy but blood adrenalectomy but blood loss is lessloss is less
Laparoscopic vs. Open Adrenalectomy
Laparoscopic Laparoscopic adrenalectomy associated adrenalectomy associated with decreased pain and with decreased pain and pain medication use, pain medication use, shorter postoperative shorter postoperative hospital stay, and a faster hospital stay, and a faster return to full activity and return to full activity and workwork
Meta-analysis of Complications of Laparoscopic vs Open Adrenalectomy
LA associated with significantly LA associated with significantly fewer complications than open fewer complications than open adrenalectomyadrenalectomy
Primary differences are in fewer Primary differences are in fewer wound, pulmonary, and wound, pulmonary, and infectious complications and a infectious complications and a lower rate of associated organ lower rate of associated organ injury (eg splenectomy)injury (eg splenectomy)
Bleeding is the #1 complication Bleeding is the #1 complication of lap adrenalectomyof lap adrenalectomy
10.9
25.2
0
5
10
15
20
25
30
%
Laparoscopic Series Open Series
Brunt LM Surg Endosc 2002;16:252-57Brunt LM Surg Endosc 2002;16:252-57
Laparoscopic Applications - Adrenal
The case for laparoscopic adrenalectomyThe case for laparoscopic adrenalectomy Review of literature addressing the role of Review of literature addressing the role of
laparoscopy in adrenal disorderslaparoscopy in adrenal disorders Studies comparing open versus laparoscopic Studies comparing open versus laparoscopic
adrenalectomy were evaluatedadrenalectomy were evaluated
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
The case for laparoscopic adrenalectomyThe case for laparoscopic adrenalectomy Conclusions:Conclusions:
Data from available literature indicates that Data from available literature indicates that laparoscopic surgery is safe and efficacious forlaparoscopic surgery is safe and efficacious for
AldosteromaAldosteromaPheochromocytomaPheochromocytomaCushing’s diseaseCushing’s diseaseIncidentalomaIncidentaloma
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
The case for laparoscopic adrenalectomyThe case for laparoscopic adrenalectomy Conclusions, cont’dConclusions, cont’d
Compared to open surgery, laparoscopic Compared to open surgery, laparoscopic adrenalectomy providesadrenalectomy providesEquivalent outcomesEquivalent outcomesDecreased morbidityDecreased morbidityFinancial benefitsFinancial benefits
The role of the laparoscopic approach to The role of the laparoscopic approach to adrenal cancer demands further studyadrenal cancer demands further studyGill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
The case for laparoscopic adrenalectomyThe case for laparoscopic adrenalectomy In the majority of patients with adrenal In the majority of patients with adrenal
disease, laparoscopy may now be disease, laparoscopy may now be considered the gold standard for surgical considered the gold standard for surgical treatmenttreatment
Gill IS, J Urol. 2001 Aug;166(2):429-36
Laparoscopic Applications - Adrenal
LA is the preferred method of removal of the vast LA is the preferred method of removal of the vast majority of adrenal tumorsmajority of adrenal tumors
Complete biochemical work-up and localization pre-opComplete biochemical work-up and localization pre-op Keys to a successful outcome: patient selection, surgical Keys to a successful outcome: patient selection, surgical
approach, meticulous dissection and hemostasisapproach, meticulous dissection and hemostasis Avoid difficult cases during “learning curve”Avoid difficult cases during “learning curve” Lap ultrasound may be useful early in one’s experience Lap ultrasound may be useful early in one’s experience
and in difficult cases, esp. obese patients with difficult to and in difficult cases, esp. obese patients with difficult to find tumorsfind tumors
Laparoscopic Applications - Spleen
Laparoscopic Laparoscopic splenectomysplenectomy
Laparoscopic Applications - Spleen
Laparoscopic Laparoscopic splenectomy: evolution splenectomy: evolution and current statusand current status Review of literature Review of literature
addressing the role of addressing the role of laparoscopic laparoscopic splenectomy (LS)splenectomy (LS)
Klinger PJ et al, Surg Laparosc Endosc. 1999 Jan;9(1):1-8
Laparoscopic Applications - Spleen
Laparoscopic Laparoscopic splenectomy: splenectomy: evolution and current evolution and current statusstatus Compared to OS, LS Compared to OS, LS
results in:results in: Fewer perioperative Fewer perioperative
complicationscomplications Less morbidityLess morbidity Shorter LOSShorter LOS
Klinger PJ et al, Surg Laparosc Endosc. 1999 Jan;9(1):1-8
Laparoscopic Applications - Spleen
LS has a limited role in LS has a limited role in hypersplenism and hypersplenism and traumatic splenic traumatic splenic injuryinjury
LS is the operation of LS is the operation of choice for spleens choice for spleens <20cm in diameter<20cm in diameter
Klinger PJ et al, Surg Laparosc Endosc. 1999 Jan;9(1):1-8
Laparoscopic Applications - Spleen
Klinger PJ et al, Surg Laparosc Endosc. 1999 Jan;9(1):1-8
Laparoscopic Applications - Hernia
Initial trocar Initial trocar placementplacement
Laparoscopic Applications - Hernia
Finger dissection of the Finger dissection of the preperitoneal spacepreperitoneal space
Laparoscopic Applications - Hernia
Insufflation of per-Insufflation of per-peritoneal spaceperitoneal space
Laparoscopic Applications - Hernia
Trocar placementTrocar placement
Laparoscopic Applications - Hernia
Dissection of hernia Dissection of hernia spacesspaces
Laparoscopic Applications - Hernia
Reduction of direct Reduction of direct hernia sachernia sac
Laparoscopic Applications - Hernia
Reduction of direct Reduction of direct hernia sachernia sac
• Easily identified Easily identified medial to the epigastric medial to the epigastric vesselsvessels
• Easily reduced away Easily reduced away from the thinned from the thinned transversalis fasciatransversalis fascia
Laparoscopic Applications - Hernia
Reduction of indirect Reduction of indirect hernia sachernia sac
In the presence of hernia:In the presence of hernia: The vas deferent is not The vas deferent is not
visiblevisible The sac is seen over The sac is seen over
the spermatic cordthe spermatic cord The sac has to be always The sac has to be always
separated from the cord separated from the cord structures prior to any structures prior to any attempt of reductionattempt of reduction
Laparoscopic Applications - Hernia
Placement of meshPlacement of mesh
Laparoscopic Applications - Hernia
Fixation of the meshFixation of the mesh Stapler Stapler Tacker Tacker Adhesive butyl-2-Adhesive butyl-2-
cyanoacrylatecyanoacrylate** Fibrin sealantFibrin sealant****
(fibrinogen plus thrombin)(fibrinogen plus thrombin) No fixationNo fixation
Laparoscopic Applications - SummaryLaparoscopic ApplicationLaparoscopic Application Is if safe?Is if safe? Feasible?Feasible? Gold Standard?Gold Standard?
Esophagus – AchalasiaEsophagus – Achalasia YesYes YesYes YesYes
Esophagus – GERDEsophagus – GERD YesYes YesYes YesYes
Stomach – Bariatrics (RNY)Stomach – Bariatrics (RNY) YesYes YesYes YesYes
Stomach – CancerStomach – Cancer YesYes YesYes NoNo
Pancreas – DiagnosticPancreas – Diagnostic YesYes YesYes NoNo
Pancreas – Therapeutic Pancreas – Therapeutic YesYes YesYes NoNo
Liver – ResectionLiver – Resection YesYes YesYes NoNo
Colon – Diverticular DiseaseColon – Diverticular Disease YesYes YesYes YesYes
Colon – MalignancyColon – Malignancy YesYes YesYes YesYes
AppendixAppendix YesYes YesYes NoNo
Adrenal Adrenal YesYes YesYes YesYes
SpleenSpleen YesYes YesYes YesYes
HerniaHernia YesYes YesYes NoNo